As per Future Market Insights, the Global Pelvic Reconstruction Market was around US$ 270.5 Mn in 2021 and is projected to exhibit at CAGR of 2.8% over the forecast period (2022-2032), surpassing US$ 366.9 Mn in 2032. Growth is due to the increased use of vaginal mesh, slings, and pessaries in the healthcare sector owing to rising cases of pelvic floor disorders.
Furthermore, increasing awareness regarding vaginal health due to growing cases of pelvic disorders and deformities have surged the need for pelvic reconstruction products. On the back of this, key players are vying to develop systems that can be approved by regulatory authorities such as the FDA.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15500
Additionally, growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is prompting the adoption of advanced systems for accurate and speedy recovery. There is also an increase in the research and development on ways to handle pelvic floor disorders by mitigating the risk factors.
Increasing use of tissue engineering to support pelvic floor and also promotes tissue repair. This is also highly biocompatible compared to the general approach of using polypropylene mesh. Hence, several ongoing research is focusing on tissue engineering such as the use of fibroblasts and stem cells is supporting the growth in pelvic reconstruction market.
Key Takeaways from Market Study
Based on product type, vaginal sling systems held approximately 2% market value share in 2021, owing to rising cases of pelvic floor disorders.
Surgical procedure is set to lead the market, in terms of procedures, and contributed around 9% of revenue in 2021.
By indication, pelvic organ prolapse is expected to register growth at a CAGR of 7% during the forecast period.
By pelvic organs, the vagina is the most affected organ and the segment held a share of about 6% in 2021.
North America is considered as the leading region with a value share of 9% in 2021, owing to the high prevalence of pelvic floor disorders in the region.
“Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe,” says an analyst of Future Market Insights.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-15500
Market Competition
The market for pelvic reconstruction consists of a number of local as well as established players within the market sphere. There is increased research and development to meet the current needs of the population.
In 2019, as per research conducted by Royal Hallamshire Hospital, UK, Ulrich et al. demonstrated that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
Onkos Surgical declared in July 2022 that its My3D® Personalized Pelvic Reconstruction system had been granted 510(k) approval.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the pelvic reconstruction market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global pelvic reconstruction market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The research study is based on the product – (vaginal mesh(biological mesh, synthetic mesh), vaginal sling systems, and vaginal pessary), by procedure (non-surgical and surgical (obliterative surgery and reconstructive surgery (native tissue repair, colporrhaphy, sacrocolpopexy, sacrohysteropexy, transvaginal graft, and sling surgery), by indication (pelvic organ prolapse (vaginal prolapse and rectal prolapse), urinary incontinence, interstitial cystitis, and fistulae), by pelvic organs (uterus, ovaries, vagina, and fallopian tubes), by end user (hospitals, ambulatory surgical centers, and specialty clinics), across seven key regions of the world.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15500
Key Players :
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation (American Medical Systems Inc.)
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
Key Market Segments Covered In Pelvic Reconstruction Industry Research
By Product:
- Vaginal Mesh
- Biological Mesh
- Synthetic Mesh
- Vaginal Sling Systems
- Vaginal Pessary
By Procedure:
- Non-Surgical
- Surgical
- Obliterative surgery
- Reconstructive surgery
- Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
- Colporrhalphy
- Sacrocolpopexy
- Sacrohysteropexy
- Transvaginal graft
- Sling Surgery
By Indication:
- Pelvic Organ Prolapse
- Vaginal Prolapse
- Rectal Prolapse
- Urinary Incontinence
- Interstitial Cystitis
- Fistulae
By Pelvic Organs:
- Uterus
- Ovaries
- Vagina
- Fallopian Tubes
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs